Cited 8 times in
Acute erythroleukemia with der(1;7)(q10;p10) as a sole acquired abnormality after treatment with azathioprine.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박태성 | - |
dc.contributor.author | 송재우 | - |
dc.contributor.author | 이경아 | - |
dc.contributor.author | 정주원 | - |
dc.contributor.author | 최종락 | - |
dc.contributor.author | 이상국 | - |
dc.date.accessioned | 2015-05-19T16:34:33Z | - |
dc.date.available | 2015-05-19T16:34:33Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0165-4608 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/106558 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | CANCER GENETICS AND CYTOGENETICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | - |
dc.subject.MESH | Azathioprine/administration & dosage | - |
dc.subject.MESH | Azathioprine/adverse effects* | - |
dc.subject.MESH | Azathioprine/therapeutic use | - |
dc.subject.MESH | Bone Marrow/pathology | - |
dc.subject.MESH | Chromosomes, Human, Pair1/genetics | - |
dc.subject.MESH | Chromosomes, Human, Pair1/ultrastructure* | - |
dc.subject.MESH | Chromosomes, Human, Pair7/genetics | - |
dc.subject.MESH | Chromosomes, Human, Pair7/ultrastructure* | - |
dc.subject.MESH | Cyclophosphamide/administration & dosage | - |
dc.subject.MESH | Cyclophosphamide/adverse effects | - |
dc.subject.MESH | Cyclophosphamide/therapeutic use | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Fatal Outcome | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypereosinophilic Syndrome/drug therapy* | - |
dc.subject.MESH | Immunosuppressive Agents/administration & dosage | - |
dc.subject.MESH | Immunosuppressive Agents/adverse effects* | - |
dc.subject.MESH | Immunosuppressive Agents/therapeutic use | - |
dc.subject.MESH | In Situ Hybridization, Fluorescence | - |
dc.subject.MESH | Karyotyping | - |
dc.subject.MESH | Leukemia, Erythroblastic,Acute/chemically induced* | - |
dc.subject.MESH | Leukemia, Erythroblastic,Acute/drug therapy | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neutropenia/etiology | - |
dc.subject.MESH | Shock, Septic/etiology | - |
dc.title | Acute erythroleukemia with der(1;7)(q10;p10) as a sole acquired abnormality after treatment with azathioprine. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Tae Sung Park | - |
dc.contributor.googleauthor | June-Won Cheong | - |
dc.contributor.googleauthor | Jaewoo Song | - |
dc.contributor.googleauthor | Kyung-A Lee | - |
dc.contributor.googleauthor | Sang-Guk Lee | - |
dc.contributor.googleauthor | Juwon Kim | - |
dc.contributor.googleauthor | Seoyoung Yoon | - |
dc.contributor.googleauthor | Jong Rak Choi | - |
dc.contributor.googleauthor | Rojin Park | - |
dc.identifier.doi | 10.1016/j.cancergencyto.2008.06.003 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01725 | - |
dc.contributor.localId | A02054 | - |
dc.contributor.localId | A02647 | - |
dc.contributor.localId | A03726 | - |
dc.contributor.localId | A04182 | - |
dc.relation.journalcode | J00443 | - |
dc.identifier.eissn | 1873-4456 | - |
dc.identifier.pmid | 18786444 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0165460808003543 | - |
dc.subject.keyword | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | - |
dc.subject.keyword | Azathioprine/administration & dosage | - |
dc.subject.keyword | Azathioprine/adverse effects* | - |
dc.subject.keyword | Azathioprine/therapeutic use | - |
dc.subject.keyword | Bone Marrow/pathology | - |
dc.subject.keyword | Chromosomes, Human, Pair1/genetics | - |
dc.subject.keyword | Chromosomes, Human, Pair1/ultrastructure* | - |
dc.subject.keyword | Chromosomes, Human, Pair7/genetics | - |
dc.subject.keyword | Chromosomes, Human, Pair7/ultrastructure* | - |
dc.subject.keyword | Cyclophosphamide/administration & dosage | - |
dc.subject.keyword | Cyclophosphamide/adverse effects | - |
dc.subject.keyword | Cyclophosphamide/therapeutic use | - |
dc.subject.keyword | Drug Therapy, Combination | - |
dc.subject.keyword | Fatal Outcome | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Hypereosinophilic Syndrome/drug therapy* | - |
dc.subject.keyword | Immunosuppressive Agents/administration & dosage | - |
dc.subject.keyword | Immunosuppressive Agents/adverse effects* | - |
dc.subject.keyword | Immunosuppressive Agents/therapeutic use | - |
dc.subject.keyword | In Situ Hybridization, Fluorescence | - |
dc.subject.keyword | Karyotyping | - |
dc.subject.keyword | Leukemia, Erythroblastic,Acute/chemically induced* | - |
dc.subject.keyword | Leukemia, Erythroblastic,Acute/drug therapy | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Neutropenia/etiology | - |
dc.subject.keyword | Shock, Septic/etiology | - |
dc.contributor.alternativeName | Park, Tae Sung | - |
dc.contributor.alternativeName | Song, Jae Woo | - |
dc.contributor.alternativeName | Lee, Kyung A | - |
dc.contributor.alternativeName | Chung, Joo Won | - |
dc.contributor.alternativeName | Choi, Jong Rak | - |
dc.contributor.affiliatedAuthor | Park, Tae Sung | - |
dc.contributor.affiliatedAuthor | Song, Jae Woo | - |
dc.contributor.affiliatedAuthor | Lee, Kyung A | - |
dc.contributor.affiliatedAuthor | Chung, Joo Won | - |
dc.contributor.affiliatedAuthor | Choi, Jong Rak | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 186 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 58 | - |
dc.citation.endPage | 60 | - |
dc.identifier.bibliographicCitation | CANCER GENETICS AND CYTOGENETICS , Vol.186(1) : 58-60, 2008 | - |
dc.identifier.rimsid | 44947 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.